Using RNA interference in a PLCß4-expressing GIST cell model, we functionally validated the pro-proliferative oncogenic attribute of PLCB4 and its expression upregulated by increased YAP1, hence providing insights into alternative non-amplified mechanism(s) that may drive PLCB4 expression. The gene discussed is YAP1; the disease is gastrointestinal stromal tumor.